Alexandra Balcom
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Alexandra Balcom is currently an Independent Director at Crescent Biopharma, Inc. since 2024.
Former roles include Director at Crescent Biopharma, Inc. (Old), Controller at Agios Pharmaceuticals, Inc., Vice President-Finance at SQZ Biotechnologies Co. from 2017 to 2021, and Chief Financial Officer & Treasurer at Nuvalent, Inc. from 2021 to 2026.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-06-02 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|
| Företag | Position | Slut |
|---|---|---|
| NUVALENT, INC. | Finansdirektör/CFO | 2026-07-15 |
| SQZ BIOTECHNOLOGIES COMPANY | Företagsledare/Principal | 2021-03-01 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Revisor | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån